A medley of molecules, and the interactions between them, mediate cancer. The latest news is that the enzyme CDK8 orchestrates cross-talk between two signalling pathways that are frequently deregulated in human cancers.
This is a preview of subscription content, log in via an institution to check access.
References
Clevers, H. Cell 127, 469–480 (2006).
Firestein, R. et al. Nature 455, 547–551 (2008).
Morris, E. J. et al. Nature 455, 552–556 (2008).
Rowland, B. D. & Bernards, R. Cell 127, 871–874 (2006).
Tetsu, O. & McCormick, F. Nature 398, 422–426 (1999).
Horowitz, J. M. et al. Proc. Natl Acad. Sci. USA 87, 2775–2779 (1990).
Hildebrandt, B. et al. Oncology 59, 344–346 (2000).
Gope, R. et al. J. Natl Cancer Inst. 82, 310–314 (1990).
Williams, J. P. et al. Mol. Cell Biol. 26, 1170–1182 (2006).
Yamasaki, L. et al. Cell 85, 537–548 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bernards, R. Entangled pathways. Nature 455, 479–480 (2008). https://doi.org/10.1038/455479a
Published:
Issue Date:
DOI: https://doi.org/10.1038/455479a
- Springer Nature Limited
This article is cited by
-
Endoplasmic reticulum Metallo protease 1, a triggering factor for unfolded protein response and promising target in colorectal cancer
Biologia (2021)
-
OncoScape: Exploring the cancer aberration landscape by genomic data fusion
Scientific Reports (2016)
-
Proteomic patterns of cervical cancer cell lines, a network perspective
BMC Systems Biology (2011)
-
E2F1 suppresses Wnt/β-catenin activity through transactivation of β-catenin interacting protein ICAT
Oncogene (2011)
-
Drug development in advanced colorectal cancer: Challenges and opportunities
Current Oncology Reports (2009)